Total Funding
30
48
Total FundingVenture - Series Unknown raised
Growth Score 30 in past quarter
-1 pts
Heat Score 48 in past quarter
1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
132899
developed an advanced wound care platform designed to be used across a broad spectrum of clinical.
- Elsa Abruzzo: Head Regulatory
Matthew Dowling: Founder and Chief Scientific Officer
About the Company
gel-e Life Sciences has developed an advanced wound care platform that can be used across a broad spectrum of clinical and non-clinical settings. By making molecular modifications to natural biopolymers, gel-e’s patented approach provides rapid hemostasis in a clean, safe healing environment. Using non-dilutive grant funding, the company has
achieved milestones such as 1 FDA Clearance, 5 issued patents, and 6 peer-reviewed publications.

